SECOND OPINION: PHARMA-BACKED REBATE RULE WOULD HIKE SENIOR PREMIUMS, BOOST DRUG COMPANY PROFITS
Jul 22, 2021
Big Pharma Wants Implementation of Misguided Policy that Does Nothing to Lower… Read More
© 2026 CSRXP- All Rights Reserved
Blog Posts
THEY SAID IT! U.S. SENATE JUDICIARY SUBCOMMITTEE HIGHLIGHTS BIG PHARMA’S ANTI-COMPETITIVE PRACTICES
Jul 14, 2021
Lawmakers Showcase How Big Pharma’s Patent Abuse Drives Out-of-Control… Read More
DOSE OF REALITY: LAWMAKERS TO PROBE BIG PHARMA PATENT ABUSE AS INNOVATION EXCUSES CRUMBLE
Jul 13, 2021
U.S. Senate Judiciary Subcommittee Hearing Tuesday Will Build on Momentum for… Read More
BIG PHARMA WATCH: JULY PRICE HIKES CLIMB TO 52
Jul 7, 2021
Brand Name Drug Companies Stick to Business-as-Usual in Third Major Round of… Read More
BIG PHARMA WATCH: HEADLINES SHOW BIOGEN ADHUHELM PRICING HAS REIGNITED URGENCY TO HOLD BIG PHARMA ACCOUNTABLE
Jun 25, 2021
Coverage Highlights Backlash Over Massive Price Tag for Unproven Treatment,… Read More
SECOND OPINION: PFIZER’S PHONY CALL FOR LOWER DRUG COSTS
Jun 22, 2021
CEO Sidesteps Big Pharma’s Pricing Practices; Pushes Proposals That Would… Read More
WHAT THEY ARE SAYING: BIOGEN’S “SIMPLY UNACCEPTABLE” ADUCANUMAB PRICING HIGHLIGHTS URGENCY FOR RX SOLUTIONS
Jun 14, 2021
Broad-based Opposition to Egregious Launch Price on Drug With Unproven… Read More
SECOND OPINION: DEBUNKING BIG PHARMA’S BOGUS INNOVATION RHETORIC
Jun 7, 2021
For far too long Big Pharma has used the excuse that research and development… Read More
THEY SAID IT! ABBVIE CEO BRAGS ON ABILITY TO HIKE PRICES IN U.S., ADMITS COMPETITION WORKS AND CONFIRMS BIG PHARMA PATENT GAMES DESIGNED FOR “PRICING POWER”
May 19, 2021
House Oversight Lawmakers Commit to Bipartisan Action to Hold Big Pharma… Read More
DOSE OF REALITY: HUMIRA: A CASE STUDY IN BIG PHARMA GREED
May 17, 2021
AbbVie CEO Headed for Capitol Hill to Answer for Indefensible Anti-Competitive… Read More
THEY SAID IT! LAWMAKERS CALL FOR BIPARTISAN ACTION TO LOWER RX PRICES IN PAIR OF HOUSE HEARINGS
May 5, 2021
Members of Congress in Both Parties Recognize Urgency for Solutions to Deliver… Read More
BIG PHARMA EARNINGS WATCH: PFIZER, ABBVIE & ASTRAZENECA
May 5, 2021
Drug Companies Top Wall Street Expectations; Pfizer Raises Guidance Based On… Read More